Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001705

CERILLIANT™ Noroxycodone Hydrochloride Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01001705 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-705 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-705 Supplier MilliporeSigma Supelco Supplier No. N0111ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Noroxycodone is a major urinary metabolite of oxycodone, an opiate drug marketed under the trade name OxyContin™ for treatment of moderate to severe pain. This certified solution standard is suitable for use as starting material in calibrators and controls for a variety of LC/MS or GC/MS applications from clinical toxicology and forensic analysis to pain prescription monitoring, urine drug testing and pharmaceutical research. Since opiate drugs are classified as controlled substances, Cerilliant offers most opiate reference standards as DEA-exempt solutions for added convenience.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 52446-25-0
Linear Formula C17H19NO4·HCl
MDL Number MFCD01861542
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 1.0 mg/mL in methanol (as free base)
Synonym Noroxycodone hydrochloride
Formula Weight 337.80
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.